Delivery Order SPE2DB22D3301-SPE2DB25FZ0ZA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,044.04 to AmerisourceBergen Drug Corp for the supply of Refresh Plus 0.5% eye drops in 30-unit quantities. This is a firm fixed price, non-competitive delivery order that was awarded on October 16, 2025, with an ultimate completion date of October 17, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,395.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply delivery under the company's existing federal contract vehicle with DLA. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,361.54 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price contract with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $1,719.02 delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (70 unit dose vials) on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.57 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,733.81 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 count) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,889.08 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-count unit dose) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50 unit dose supplies) valued at $1,087.55 under a firm fixed-price contract. This non-set-aside delivery order was awarded on April 30, 2025, with an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,376.52 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,243.20 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on July 24, 2025, with completion targeted for July 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0ZADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,105.42 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (70 units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order represents a non-competitive award under an existing contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support, enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The underlying IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/15/25 |